Charanjeet Kaur

Dr. Charanjeet Kaur

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2023 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
CKCharanjeet Kaur
Charanjeet Kaur
PWPei-Zhe Wu
Pei-Zhe Wu
JOJennifer T. O'MAlley
Jennifer T. O'MAlley
MLM. Charles Liberman
M. Charles Liberman
Several lines of evidence have suggested that steeply sloping audiometric losses are caused by hair cell degeneration, while flat audiometric losses are caused by strial atrophy, but this concept has never been rigorously tested in human specimens. Here, we systematically compare audiograms and cochlear histopathology in 160 human cases from the archival collection of celloidin-embedded temporal bones at the Massachusetts Eye and Ear. The dataset included 106 cases from a prior study of normal-aging ears, and an additional 54 cases selected by combing the database for flat audiograms. Audiogram shapes were classified algorithmically into five groups according to the relation between flatness (i.e., SD of hearing levels across all frequencies) and low-frequency pure-tone average (i.e., mean at 0.25, 0.5, and 1.0 kHz). Outer and inner hair cell losses, neural degeneration, and strial atrophy were all quantified as a function of cochlear location in each case. Results showed that strial atrophy was worse in the apical than the basal half of the cochlea and was worse in females than in males. The degree of strial atrophy was uncorrelated with audiogram flatness. Apical atrophy was correlated with low-frequency thresholds and basal atrophy with high-frequency thresholds, and the former correlation was higher. However, a multivariable regression with all histopathological measures as predictors and audiometric thresholds as the outcome showed that strial atrophy was a significant predictor of threshold shift only in the low-frequency region, and, even there, the contribution of outer hair cell damage was larger.SIGNIFICANCE STATEMENTCochlear pathology can only be assessed postmortem; thus, human cochlear histopathology is critical to our understanding of the mechanisms of hearing loss. Dogma holds that relative damage to sensory cells, which transduce mechanical vibration into electrical signals, versus the stria vascularis, the cellular battery that powers transduction, can be inferred by the shape of the audiogram, that is, down-sloping (hair cell damage) versus flat (strial atrophy). Here we quantified hair cell and strial atrophy in 160 human specimens to show that it is the degree of low-frequency hearing loss, rather than the audiogram slope, that predicts strial atrophy. Results are critical to the design of clinical trials for hearing-loss therapeutics, as current drugs target only hair cell, not strial, regeneration.

25 May 2023 in Hearing Research
Verified
Journal Article
Closed access
CKCharanjeet Kaur
Charanjeet Kaur
MOMcKayla Van Orden
McKayla Van Orden
JOJennifer T. O'MAlley
Jennifer T. O'MAlley
PWPei-Zhe Wu
Pei-Zhe Wu
MLM. Charles Liberman
M. Charles Liberman

1 November 2018 in Journal of Chemical Neuroanatomy
Verified
Journal Article
Closed access
CKCharanjeet Kaur
Charanjeet Kaur
IPI. Pal
I. Pal
SSS. Saini
S. Saini
TJT.G. Jacob
T.G. Jacob
TNTapas Chandra Nag
Tapas Chandra Nag
TRT.S. Roy
T.S. Roy

1 October 2019 in Hearing Research
Verified
Journal Article
Closed access
SSShubhi Saini
Shubhi Saini
CKCharanjeet Kaur
Charanjeet Kaur
IPIndra Pal
Indra Pal
PKPunit Kumar
Punit Kumar
TJTony George Jacob
Tony George Jacob
TRTara Sankar Roy
Tara Sankar Roy

14 February 2026 in Hearing Research
Verified
Journal Article
Closed access
CKCharanjeet Kaur
Charanjeet Kaur
PWPei-Zhe Wu
Pei-Zhe Wu
JOJennifer T. O’MAlley
Jennifer T. O’MAlley
MLM. Charles Liberman
M. Charles Liberman

24 April 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
CKCharanjeet Kaur
Charanjeet Kaur
MOMcKayla Van Orden
McKayla Van Orden
JOJennifer T. O’malley
Jennifer T. O’malley
PWPei-Zhe Wu
Pei-Zhe Wu
MLM. Charles Liberman
M. Charles Liberman
Animal studies have shown that the supporting-cells surviving in the organ of Corti after cochlear insult can be transdifferentiated into hair cells as a treatment for sensorineural hearing loss. Clinical trials of small-molecule therapeutics have been undertaken, but little is known about how to predict the pattern and degree of supporting-cell survival based on audiogram, hearing loss etiology or any other metric obtainable pre-mortem. To address this, we systematically assessed supporting-cell and hair cell survival, as a function of cochlear location in 274 temporal bone cases from the archives at the Massachusetts Eye and Ear and compared the histopathology with the audiograms and hearing-loss etiologies. Results showed that supporting-cell survival was always significantly greater in the apical half than the basal half of the cochlea, that inner pillars were more robust than outer pillars or Deiters’ cells, and that total replacement of all supporting cells with a flat epithelium was rare outside of the extreme basal 20% of the cochlea. Supporting cell survival in the basal half of the cochlea was better correlated with the slope of the audiogram than with the mean high-frequency threshold per se: i.e. survival was better with flatter audiograms than with steeply down-sloping audiograms. Cochlear regions with extensive hair cell loss and exceptional supporting cell survival were most common in cases with hearing loss due to ototoxic drugs. Such cases also tended to have less pathology in other functionally critical structures, i.e. spiral ganglion neurons and the stria vascularis. Highlights Supporting cell survival was systematically assessed in 274 human cochleas Supporting cell survival was better with flat than with down-sloping audiograms Supporting cell survival was most robust when hearing loss was from ototoxic drugs Ototoxic cases also showed less pathology in other critical cochlear structures The data can inform clinical trials for regeneration via supporting cell conversion